BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31277922)

  • 1. Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.
    Tada T; Iijima H; Kobayashi N; Yoshida M; Nishimura T; Kumada T; Kondo R; Yano H; Kage M; Nakano C; Aoki T; Aizawa N; Ikeda N; Takashima T; Yuri Y; Ishii N; Hasegawa K; Takata R; Yoh K; Sakai Y; Nishikawa H; Iwata Y; Enomoto H; Hirota S; Fujimoto J; Nishiguchi S
    Ultrasound Med Biol; 2019 Oct; 45(10):2679-2687. PubMed ID: 31277922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
    Bae JS; Lee DH; Lee JY; Kim H; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK; Choi BI
    Eur Radiol; 2019 Dec; 29(12):6499-6507. PubMed ID: 31175413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
    Hwang SM; Cho KY
    Eur Radiol; 2023 Nov; 33(11):8353-8365. PubMed ID: 37195431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
    Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
    Hsu PK; Wu LS; Su WW; Su PY; Chen YY; Hsu YC; Yen HH; Wu CL
    PLoS One; 2021; 16(10):e0254892. PubMed ID: 34653177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging.
    Rehman A; Darira J; Hamid K; Ahmed MS; Shazlee MK; Amirali A
    Cureus; 2022 Mar; 14(3):e23435. PubMed ID: 35494925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Jang JK; Kim SY; Yoo IW; Cho YB; Kang HJ; Lee DH
    Eur Radiol; 2022 Mar; 32(3):2070-2077. PubMed ID: 34549325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction.
    Tada T; Kumada T; Toyoda H; Nakamura S; Shibata Y; Yasuda S; Watanuki Y; Tsujii K; Fukuda N; Fujioka M; Takeshima K; Niwa F; Ogawa S; Hashinokuchi S; Kataoka S; Ichikawa H; Iijima H
    Hepatol Res; 2020 Dec; 50(12):1319-1327. PubMed ID: 32876367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
    Kuroda H; Abe T; Fujiwara Y; Nagasawa T; Takikawa Y
    J Med Ultrason (2001); 2021 Oct; 48(4):471-480. PubMed ID: 34415481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective comparison of three ultrasound-based techniques in quantitative diagnosis of hepatic steatosis in NAFLD.
    Zhu Y; Yin H; Zhou D; Zhao Q; Wang K; Fan Y; Chen K; Han H; Xu H
    Abdom Radiol (NY); 2024 Jan; 49(1):81-92. PubMed ID: 37950767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis.
    Ferraioli G; Maiocchi L; Savietto G; Tinelli C; Nichetti M; Rondanelli M; Calliada F; Preda L; Filice C
    J Ultrasound Med; 2021 Jul; 40(7):1325-1332. PubMed ID: 32960457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis.
    Hsu PK; Wu LS; Yen HH; Huang HP; Chen YY; Su PY; Su WW
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
    Tada T; Kumada T; Toyoda H; Kobayashi N; Sone Y; Oguri T; Kamiyama N
    AJR Am J Roentgenol; 2019 Feb; 212(2):332-341. PubMed ID: 30476453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation.
    Welman CJ; Saunders J; Zelesco M; Abbott S; Boardman G; Ayonrinde OT
    J Med Imaging Radiat Oncol; 2023 Feb; 67(1):45-53. PubMed ID: 35466506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography.
    Kwon EY; Kim YR; Kang DM; Yoon KH; Lee YH
    Clin Imaging; 2021 Aug; 76():53-59. PubMed ID: 33549920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.
    Thiele M; Rausch V; Fluhr G; Kjærgaard M; Piecha F; Mueller J; Straub BK; Lupșor-Platon M; De-Ledinghen V; Seitz HK; Detlefsen S; Madsen B; Krag A; Mueller S
    J Hepatol; 2018 May; 68(5):1025-1032. PubMed ID: 29343427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
    Fujiwara Y; Kuroda H; Abe T; Ishida K; Oguri T; Noguchi S; Sugai T; Kamiyama N; Takikawa Y
    Ultrasound Med Biol; 2018 Nov; 44(11):2223-2232. PubMed ID: 30077415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis.
    Sugimoto K; Abe M; Oshiro H; Takahashi H; Kakegawa T; Tomita Y; Yoshimasu Y; Takeuchi H; Itoi T
    J Med Ultrason (2001); 2021 Oct; 48(4):615-621. PubMed ID: 34453648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
    Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
    BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.